中国消费者报北京讯记者孟刚）4月17日，国家药品监督管理局发布公告，根据《药品管理法》等有关规定，国家药品监督管理局决定自即日起停止安喘片、盐酸克仑特罗膜、盐酸克仑特罗栓、复方盐酸克仑特罗栓、复方羟丙
https://image11.m1905.cn/uploadfile/2024/0522/thumb_1_118_74_20240522090140763453.jpg|https://image1
http://upload.mnw.cn/2024/0524/1716516981989.jpg
https://image11.m1905.cn/uploadfile/2024/0511/thumb_1_118_74_20240511040205294694.jpg|https://image1
http://upload.mnw.cn/2020/0527/1590540127677.jpg
http://www.mtksj.com/uploads/allimg/220617/1-22061FU324510.jpg|http://www.mtksj.com/uploads/allimg/2
https://image11.m1905.cn/uploadfile/2024/0501/thumb_1_118_74_20240501113636547152.jpg|https://image1
http://upload.mnw.cn/2024/0522/1716367094253.jpg
https://image11.m1905.cn/uploadfile/2024/0501/20240501110346158020.jpg|https://image11.m1905.cn/uplo
https://mma.prnasia.com/media2/2282533/image_5028373_21157040.jpg?p=medium600|https://mma.prnasia.co